TABLE 2.

PREVALENCE OF SYMPTOMS, CHEST RADIOGRAPH ABNORMALITIES, AND LABORATORY FINDINGS AT SCREENING, BY HIV STATUS (N = 1,955)

	HIV-uninfected (N = 1,388)		HIV-infected (N = 567)
Screening Method	N	%	N	%	P Value
Symptom
New or worsening cough
Any duration	29	2.1	20	3.5	0.079
>2 wk	12	0.9	9	1.6	0.224
>3 wk	9	0.7	9	1.6	0.065
New or worsening sputum production	12	0.9	13	2.3	0.015
Hemoptysis	11	0.8	3	0.5	0.769
Night sweats	69	5.0	49	8.6	0.003
Fever
Any duration	19	1.4	11	1.9	0.417
>2 wk	6	0.4	4	0.7	0.488
>3 wk	6	0.4	4	0.7	0.488
Weight loss >5kg	62	4.5	39	6.9	0.032
At least one symptom	133	9.6	75	13.2	0.023
New or changing radiological abnormality	27	1.9	11	1.9	>0.999
Smear positive
First specimen	19	1.4	10	1.8	0.538
Second specimen	22	1.6	6	1.1	0.529
Combined	22	1.6	10	1.8	0.844
Culture positive
First specimen	18	1.3	16	2.8	0.034
Second specimen	20	1.4	13	2.3	0.181
Combined	22	1.6	18	3.2	0.033

P values are from a Fisher exact test for differences in prevalences by HIV status. Data on presence of cough, hemoptysis or night sweats were missing for each of three separate HIV-uninfected participants. Data on duration of cough were missing for five HIV-uninfected participants and one HIV-infected participant. Data on duration of fever were missing for three HIV-uninfected participants and two HIV-infected participants.